24.12.2014 Views

National Healthcare Disparities Report - LDI Health Economist

National Healthcare Disparities Report - LDI Health Economist

National Healthcare Disparities Report - LDI Health Economist

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Effectiveness of Care<br />

Treatment: Recommended Care for Breast Cancer<br />

Different diagnostic and treatment options exist for various types of cancer. Some aspects of cancer care are<br />

well established as beneficial and are commonly recommended. The appropriateness of recommended care<br />

depends on different factors, such as the stage or extent of the cancer within the body (especially whether the<br />

disease has spread from the original site to other parts of the body). Other types of care are important for<br />

accurate diagnosis, such as ensuring adequate examination of lymph nodes when surgery is performed.<br />

Figure 2.3. Women with clinical Stage I-IIb breast cancer who received axillary node dissection or<br />

sentinel lymph node biopsy at the time of lumpectomy or mastectomy, by race and ethnicity, 2004-2008<br />

Chapter 2 Cancer<br />

100 White Black<br />

95<br />

90<br />

NHOPI<br />

2008 Achievable<br />

Benchmark: 97%<br />

AI/AN<br />

Asian<br />

100<br />

95<br />

90<br />

Total Non-Hispanic White<br />

Hispanic<br />

2008 Achievable Benchmark: 97%<br />

Percent<br />

85<br />

Percent<br />

85<br />

80<br />

80<br />

75<br />

Z<br />

0<br />

2004<br />

2005<br />

2006<br />

2007<br />

2008<br />

75<br />

Z<br />

0<br />

2004<br />

2005<br />

2006<br />

2007<br />

2008<br />

Key: NHOPI = Native Hawaiian or Other Pacific Islander; AI/AN = American Indian or Alaska Native.<br />

Source: Commission on Cancer, American College of Surgeons and American Cancer Society, <strong>National</strong> Cancer Data Base, 2004-2008.<br />

Denominator: Women with Stage I-IIb breast cancer undergoing lumpectomy or mastectomy.<br />

n The percentage of women with clinical Stage I-IIb breast cancer who received axillary node<br />

dissection or sentinel lymph node biopsy at the time of lumpectomy or mastectomy increased from<br />

85% in 2004 to 94% in 2008 (Figure 2.3). Significant improvement was observed among all racial<br />

and ethnic groups except AI/ANs.<br />

n In all years, Asian women were more likely than White women to receive axillary node dissection or<br />

sentinel lymph node biopsy.<br />

n The 2008 top 5 State achievable benchmark was 97%. vi At the current rate of increase, most women<br />

could achieve the benchmark in 1 year.<br />

vi<br />

The top 5 States contributing to the achievable benchmark are Minnesota, Mississippi, Nevada, Oklahoma, and South Dakota.<br />

54 <strong>National</strong> <strong><strong>Health</strong>care</strong> <strong>Disparities</strong> <strong>Report</strong>, 2011

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!